Elsevier

Metabolism

Volume 58, Issue 8, August 2009, Pages 1185-1190
Metabolism

Effect of red wine on urinary protein, 8-hydroxydeoxyguanosine, and liver-type fatty acid–binding protein excretion in patients with diabetic nephropathy

https://doi.org/10.1016/j.metabol.2009.03.019Get rights and content

Abstract

The aim of the present study was to determine whether red or white wine affects urinary protein, 8-hydroxydeoxyguanosine (8-OHdG), and liver-type fatty acid–binding protein (L-FABP) excretion in type 2 diabetic nephropathy patients. Twenty-four type 2 diabetes mellitus patients with nephropathy were randomly allocated to drink a 118-mL (4-oz) glass of red wine (n = 12, group A) or white wine (n = 12, group B) daily for 6 months. Twelve type 2 diabetes mellitus patients with nephropathy who did not drink any wines served as control subjects (group C). Serum creatinine, 24-hour creatinine clearance, hemoglobin A1c, urinary protein, urinary 8-OHdG, and urinary L-FABP were measured before and 3 and 6 months after the start of the study. In groups A, B, and C, serum creatinine, 24-hour creatinine clearance, and hemoglobin A1c changed little during the experimental period. However, urinary protein, 8-OHdG, and L-FABP excretions were significantly decreased at 3 (P < .05) and 6 months (P < .01) compared with the baseline values in group A. In contrast, these markers changed little during the experimental period in groups B and C. Thus, these urinary markers were significantly lower in group A than in groups B and C at 3 and 6 months. These results suggest that red wine is renoprotective whereas white wine has no such effect in type 2 diabetes mellitus patients with nephropathy. The renoprotective effect of red wine may be due in part to its ability to reduce oxidative stress.

Introduction

Oxidative stress is a central pathogenic mechanism underlying ischemic heart disease, atherosclerosis, and other chronic diseases [1]. The kidney is particularly vulnerable to damage caused by reactive oxygen species, probably because of the abundance of polyunsaturated fatty acids contained in renal lipids [2]. Reactive oxygen species are involved in the pathogenesis of glomerulosclerosis and tubulointerstitial fibrosis [2]. Epidemiologic studies have suggested beneficial effects of dietary polyphenols in reducing the risk of chronic diseases by reducing oxidative stress [3]. The beneficial effects of red wine polyphenols include prevention and/or attenuation of myocardial fibrosis, reduction in aortic wall thickening, and improvement in vascular function [4].

Diabetic nephropathy is a serious microvascular complication of diabetes and one of the main causes of end-stage renal disease. Many studies have revealed that increased oxidative stress is a major pathophysiologic mechanism underlying development of diabetic nephropathy. Treatment with a polyphenolic phytoalexin present in red wine significantly attenuated renal dysfunction and oxidative stress in diabetic rats [5]. Consumption of a moderate amount of red wine may have beneficial effects toward prevention of cardiovascular disease in diabetes patients [6]. In healthy persons, red wine has more antioxidant activity than white wine by virtue of its higher content of polyphenol [7]. However, little is known about the effect of white wine on renal function.

Liver-type fatty acid–binding protein (L-FABP) of 14.4 kd is expressed in proximal tubules of the human kidney [8]. Various pathophysiologic stresses on the proximal tubules such as significant proteinuria induce up-regulation of human L-FABP gene expression, resulting in increased urinary L-FABP excretion [8]. Urinary L-FABP levels reflect the clinical progression of chronic kidney disease. Urinary 8-hydroxydeoxyguanosine (8-OHdG) has been reported to serve as a sensitive biomarker of oxidative DNA damage [9], and its excretion is significantly correlated with the severity of tubulointerstitial lesions in patients with diabetic nephropathy [10]. The aim of the present study was to determine whether consumption of red wine or white wine affects urinary protein, 8-OHdG, and L-FABP excretion in type 2 diabetic nephropathy patients.

Section snippets

Subjects and methods

Thirty-six patients with type 2 diabetic nephropathy (23 men and 13 women; age, 55 ± 11 years) were enrolled in the study. Diagnosis was based on clinical symptoms including chronic diabetes, increased urinary albumin excretion and retinopathy, laboratory data, or histologic findings according to the Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus [11]. Diabetic nephropathy was defined as at least 2 of 3 measurements of the albumin-creatinine ratio done

Results

There were no adverse effects including hypoglycemia during 6 months in all subjects. Clinical and laboratory baseline data of each group are shown in Table 1. After 6 months, the intake of fruit, vegetables, fish, meat, and polyunsaturated fatty acids was similar in the 3 groups (statistically not significant). We found a similar intake of total calories between the 3 groups (A, 1660 ± 140 kcal/d; B, 1640 ± 120 kcal/d; C, 1680 ± 130 kcal/d) (statistically not significant). There were no

Discussion

In the present study, we first observed that red, but not white, wine reduced urinary protein, urinary 8-OHdG, and urinary L-FABP levels in patients with diabetic nephropathy. Previous studies of tubulointerstitial injury as well as glomerular injury in diabetes may provide additional insight into the pathogenesis of diabetic nephropathy and lead to the identification of targets for therapeutic intervention [16]. We reported previously that urinary L-FABP appears to be associated with the

References (31)

  • PerezD.D. et al.

    Wine, diet, antioxidant defenses, and oxidative damage

    Ann N Y Acad Sci

    (2002)
  • RodrigoR. et al.

    Renal damage mediated by oxidative stress: a hypothesis of protective effects of red wine

    Free Radical Biol Med

    (2002)
  • KimH.Y. et al.

    Effects of phenol-depleted and phenol-rich diets on blood markers of oxidative stress, and urinary excretion of quercetin and kaempferol in healthy volunteers

    J Am Coll Nutr

    (2003)
  • PechanovaO. et al.

    Beneficial effects of provinols: cardiovascular system and kidney

    Physiol Res

    (2006)
  • SharmaS. et al.

    Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats

    Pharmacology

    (2006)
  • MarfellaR. et al.

    Effect of moderate red wine intake on cardiac prognosis after recent acute myocardial infarction of subjects with type 2 diabetes mellitus

    Diabet Med

    (2006)
  • PignatelliP. et al.

    Polyphenols synergistically inhibit oxidative stress in subjects given red and white wine

    Atherosclerosis

    (2006)
  • Kamijo-IkemoriA. et al.

    Liver-type fatty acid–binding protein attenuates renal injury induced by unilateral ureteral obstruction

    Am J Pathol

    (2006)
  • XuG.W. et al.

    Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy

    J Pharm Biomed Anal

    (2004)
  • KanauchiM. et al.

    Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy

    Nephron

    (2002)
  • Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

    Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

    Diabetes Care

    (1999)
  • MarfellaR. et al.

    Effect of moderate red wine intake on cardiac prognosis after recent acute myocardial infarction of subjects with type 2 diabetic mellitus

    Diabetic Med

    (2006)
  • KamijoA. et al.

    Urinary fatty acid–binding protein as a new clinical marker of the progression of chronic renal disease

    J Lab Clin Med

    (2004)
  • SaitoS. et al.

    Quantitative determination of urinary 8-hydroxydeoxyguanosine (8-OH-dg) by using ELISA

    Res Commun Mol Pathol Pharmacol

    (2000)
  • NakamuraT. et al.

    Effect of pitavastatin on urinary liver-type fatty acid–binding protein levels in patients with early diabetic nephropathy

    Diabetes Care

    (2005)
  • Cited by (22)

    • Interventions targeted at oxidatively generated modifications of nucleic acids focused on urine and plasma markers

      2019, Free Radical Biology and Medicine
      Citation Excerpt :

      From the title and abstract of the 6613 identified studies, a total of 232 were selected for full reading. Thirty-five studies [94–128] were identified as having measured 8-oxodG in plasma and 78 studies [11,104,129–204] were identified as having measured 8-oxodG/creatinine in urine; these were selected for comparing the concentrations between analysis procedures. None of the studies used LC-ECD and LC-MS/MS methods for determining 8-oxodG in plasma; thus, we used non-intervention studies as references for the LC-ECD [82,205] and LC-MS/MS methods [206–210].

    • Thérapie nutritionnelle

      2013, Canadian Journal of Diabetes
      Citation Excerpt :

      Lorsqu'il est consommé avec des aliments, l'alcool ne cause ni hyperglycémie ni hypoglycémie (164). Chez les personnes atteintes de diabète de type 2, la consommation quotidienne modérée de vin rouge pendant 12 mois inverse le stress oxydatif et l’inflammation associés à l’infarctus du myocarde (165); chez les personnes atteintes d’une néphropathie, celle-ci exerce des effets rénoprotecteurs et hypotensifs après 6 mois; ces effets n’ont pas été observés avec le vin blanc (166). Par contre, plus la consommation d’alcool augmente, plus l’acuité visuelle décline mais sans que la rétinopathie ne s’aggrave (167).

    • Nutrition Therapy

      2013, Canadian Journal of Diabetes
      Citation Excerpt :

      Moderate alcohol consumption (6 to 18 g/day) is associated with a 25% to 66% lower risk of total and fatal CHD in persons with type 2 diabetes (163) and, consumed with food, does not cause hyperglycemia or hypoglycemia (164). Daily moderate red wine consumption for 12 months reverses the increased oxidative stress and inflammation associated with MI in persons with type 2 diabetes (165) and shows renoprotective effects and lower blood pressure after 6 months in those with nephropathy; effects not observed with white wine (166). In contrast, visual acuity declines, but retinopathy does not, with increasing amounts of alcohol intake (167).

    • Changes in urinary albumin excretion, inflammatory and oxidative stress markers in ADPKD patients with hypertension

      2012, American Journal of the Medical Sciences
      Citation Excerpt :

      Urinary 8-OHdG has been reported to serve as a sensitive biomarker of oxidative DNA damage in vivo.26 Urinary 8-OHdG might also be useful for the assessment of diabetic nephropathy,27 IgA nephropathy28 and septic shock.29 Renal oxidative stress due to decreased antioxidant protection has been shown to result in increased cell proliferation, increased extracellular matrix synthesis, increased inflammatory cell infiltration and increased apoptosis,30 pathogenic features all commonly attributed to cystic kidneys.31

    • Urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine as a biomarker in type 2 diabetes

      2011, Free Radical Biology and Medicine
      Citation Excerpt :

      Only a few studies have been performed to assess the effect of lifestyle intervention on 8-oxodG excretion in type 2 diabetes patients. Nojima et al. found that 12 months of moderate-intensity aerobic exercise reduced 8-oxodG excretion significantly [41], and Nakamura et al. reported that 4 oz red wine daily for 6 months reduced 8-oxodG in type 2 diabetes patients with nephropathy [42]. Hinokio et al. found that the incidence of macroalbuminuria was increased in type 2 diabetes patients with higher excretion of 8-oxodG in urine compared with patients with moderate or lower excretion of 8-oxodG (P < 0.0001), and multivariate logistic regression analysis suggested that urinary 8-oxodG was the strongest predictor of nephropathy among several known risk factors [31].

    View all citing articles on Scopus
    View full text